Lansoprazole, Ranitidine, and Metoclopramide: Comparison of practice patterns at 4 level III NICUs within one healthcare system

Advances in Neonatal Care

Volumn 9, Issue 3, 2009, Pages 129-131

  Barnum, Brenda ^a   Baer, Vickie L ^a   Scoffield, Scott H ^a   Lambert, Diane K ^a   Cook, Mike ^a   Christensen, Robert D ^a  

^a McKay Dee Hospital Center   (United States)

Author keywords

Gastroesophageal reflux; Lansoprazole (Prevacid); Medications; Metaclopramide (Reglan); Practice patterns; Ranitidine (Zantac)

Indexed keywords

2 [[(2 PYRIDYL)METHYL]SULFINYL]BENZIMIDAZOLE DERIVATIVE; ANTIULCER AGENT; LANSOPRAZOLE; METOCLOPRAMIDE; PROTON PUMP INHIBITOR; RANITIDINE;

ARTICLE; CLINICAL PRACTICE; COMMUNITY HOSPITAL; COMPARATIVE STUDY; DRUG MONITORING; GASTROESOPHAGEAL REFLUX; HUMAN; MEDICAL RECORD; NEWBORN; NEWBORN INTENSIVE CARE; ORGANIZATION AND MANAGEMENT; PRACTICE GUIDELINE; RETROSPECTIVE STUDY; STATISTICS; TEACHING HOSPITAL; UNITED STATES; UTILIZATION REVIEW;

2-PYRIDINYLMETHYLSULFINYLBENZIMIDAZOLES; ANTI-ULCER AGENTS; DRUG MONITORING; GASTROESOPHAGEAL REFLUX; GUIDELINE ADHERENCE; HOSPITALS, COMMUNITY; HOSPITALS, TEACHING; HUMANS; INFANT, NEWBORN; INTENSIVE CARE UNITS, NEONATAL; MEDICAL RECORDS; METOCLOPRAMIDE; PHYSICIAN'S PRACTICE PATTERNS; PROTON PUMP INHIBITORS; RANITIDINE; RETROSPECTIVE STUDIES; UTAH;

EID: 70349197755     PISSN: 15360903     EISSN: None     Source Type: Journal    
DOI: 10.1097/ANC.0b013e3181a88358     Document Type: Article

References (9)

1. Clark RH, Bloom BT, Spitzer AR, Gerstmann DR. Reported medication use in the neonatal intensive care unit: data from a large national data set. Pediatrics. 2006;1 17:1979-1987.
2. Guillet R, Stoll, B, Cotton M, et al. Association of H2 blocker therapy and higher incidence of necrotizing enterocolitis in very low birth weight infants. Pediatrics. 2006;117:e137-e142.
3. Patole S. Association of H2 blocker therapy and higher incidence of necrotizing enterocolitis: a case of excessive collateral damage? Pediatrics. 2006;117 (2):531-532.
4. Bainconi S, Gudavalli M, Sutija VG, Lopez AL, Barillas-Arias L, Ron N. Ranitidine and late-onset sepsis in the neonatal intensive care unit. J Perinatal Med. 2007;35(2):147-150.
5. Taketomo CK, Hodding JH, Kraus DM. Pediatric Dosage Handbook. 13th ed. Hudson, OH: Lexi-Comp; 2007:821.
6. Young TE, Mangum B. Neofax: A Manual of Drugs Used in Neonatal Care. 20th ed. Montvale, NJ: Thompson Healthcare; 2007:203-206.
7. Cothran DS, Borowitz SM, Sutphen JL, Dudley SM, Donowitz LG. Alterations of normal gastric flora in neonates receiving ranitidine. J Perinatol. 1997; 17(5):383-388.
8. Graham PL III, Begg MD, Larson E, Della-Latta P, Allen A, Saiman L. Risks factors for late onset gram-negative sepsis in low birth weight infants hospitalized in the neonatal intensive care unit. Pediatr Infect Dis J. 2006; 25(2):113-117.
9. Malcolm WF, Gantz M, Martin RJ, Goldstein RF, Goldberg RN, Cotton CM; National Institute of Child Health and Human Development Neonatal Research Network. Use of medications for gastroesphageal reflux at discharge among extremely low birth weight infants. Pediatrics. 2008;121:22-27.